October 14, 2026 CVS to pay $315M to settle opioid prescribing allegations October 14, 2026 MultiCare, Samaritan combination to close in November October 14, 2026 Centene joins insurers waiving prior authorizations for top providers October 14, 2026 STAT+: FDA adcomm members’ ties to industry under scrutiny October 14, 2026 STAT+: The startup chasing ‘general biological intelligence’ October 14, 2026 STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more October 14, 2026 STAT+: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccine October 14, 2026 New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability October 14, 2026 STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI October 14, 2026 Opinion: How states can resist the potential Trump vaccine shortages October 14, 2026 Opinion: We think a baby’s gut microbiome could be key to lifelong brain health October 13, 2026 Unprecedented levels of trauma: One in five Israelis haven’t regained function post Oct. 7 – study October 13, 2026 STAT+: BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion October 13, 2026 STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds October 13, 2026 Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69 October 13, 2026 UnitedHealth Raises Earnings Forecast, Targets Medicare Advantage Growth in 2027 October 13, 2026 UnitedHealth eyes Medicare Advantage opportunities, bolstered by Q3 profit growth October 13, 2026 Humana enters $2.8B primary care joint venture with BlackRock October 13, 2026 STAT+: Doctors are giving generously to doctors running for office October 13, 2026 STAT+: Animosity in North Carolina, and MA shooting stars October 13, 2026 Suki raises $90M in Series E round to create AI agents October 13, 2026 STAT+: FTC demands Martin Shkreli divest his pharma stocks October 13, 2026 New bill would overhaul the No Surprises Act’s arbitration process October 13, 2026 Alignment sues CMS over 2027 Medicare Advantage star ratings crash October 13, 2026 STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more October 13, 2026 STAT+: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE October 13, 2026 How many ways can the Trump administration clamp down on international researchers? October 13, 2026 Opinion: Lethal injection will never be the same after Christa Pike’s botched execution October 13, 2026 STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug October 13, 2026 Opinion: STAT+: The epidemic of learned helplessness in physicians October 12, 2026 Hospitals sue over revamped 340B rebate pilot October 12, 2026 HHS launches new plan to strengthen vaccine injury research, reporting October 12, 2026 Your service area is not your market October 12, 2026 What Gen Z healthcare workers are really looking for October 10, 2026 Americans trust science more than peers around the world, survey shows October 9, 2026 STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role October 9, 2026 STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot October 9, 2026 STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds October 9, 2026 STAT+: Medicare Advantage star ratings trigger new bonuses, and uncertainty October 9, 2026 STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug 1 2 3 … 65 Next Page 2026-03-30
